Compare Bio Protocol (BIO) vs Gitcoin (GTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Gitcoin — how do they compare? Bio Protocol trades at Rp432.53 (market cap Rp982,16M, Rp150,34M 24h volume), while Gitcoin trades at Rp1,420 (market cap Rp123,57M, Rp42,18M 24h volume). The key difference: Bio Protocol is far larger — about 7.9× Gitcoin's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Gitcoin's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Gitcoin for 24 Days on average.
| BIO | GTC | |
|---|---|---|
Market Cap | Rp982,16M | Rp123,57M |
Volume (24h) | Rp150,34M | Rp42,18M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 87,5M GTC |
Typical Hold Time | 18 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Gitcoin (GTC) is currently trading at Rp1,451, with a market cap of Rp126.9 million and a bearish technical signal. The price is at the pivot point, with support at Rp1,411 and resistance at Rp1,485. RSI indicators are neutral, while ADX signals a strong trend. Recent ecosystem activity includes ongoing grants rounds and developer engagement, though no major protocol upgrades were reported recently.
Overall outlook is cautious due to bearish technicals and low market cap, which increases volatility risk. Key opportunities lie in potential ecosystem growth from grant funding, but investors should be wary of thin liquidity and regulatory uncertainties in the crypto space.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Gitcoin
Gitcoin develops tools that help communities fund, build, and protect important projects. Its Gitcoin Grants Program has distributed over $54 million to early-stage builders supporting public goods in DeFi, climate, open source, and more. Key products include Gitcoin Grants Stack (a grants management platform), Allo Protocol (an open-source funding system), and Gitcoin Passport (a decentralized identity tool). GTC, Gitcoin’s governance token launched in May 2021, is used to create and fund the DAO that oversees Gitcoin.
Read more on GTC →
